Dabigatran Impurity P |
|
Synonyms: Ethyl 3-(1-Methyl-2-oxo-N-(pyridin-2-yl)-2,3-dihydro-1H-benzo[d]imidazole-5-carboxamido)propanoate;N-[(2,3-Dihydro-1-methyl-2-oxo-1H-benzimidazol-5-yl)carbonyl]-N-2-pyridinyl-beta-Alanine Ethyl Ester; | |
Cat. No.: D00117 | CAS No.: 1642853-67-5 |
MDL.: | Formula: C19H20N4O4 |
F.W.368.39 | Purity: 99% |
Storage: | |
  |
Catalog Number: | D00117 | CAS No.: | 1642853-67-5 | |
MDL: | Formula: | C19H20N4O4 | ||
F.W.: | 368.39 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | M.P.: | |||
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | Stability: | |||
Storage: | Category: | Reference Standard | ||
Reference: | Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002), Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002), Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005), | |||
Application: | Ethyl 3-(1-Methyl-2-oxo-N-(pyridin-2-yl)-2,3-dihydro-1H-benzo[d]imidazole-5-carboxamido)propanoate is an impurity of Dabigatran, a nonpeptide, direct thrombi inhibitor. Antithrombotic. | |||
Category: | Aromatics, Heterocycles, Metabolites & Impurities, Nucleotides, Bases & Related Reagents, Pharmaceuticals, Intermediates & Fine Chemicals |